Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased (1)H NMR-Linked Metabolomics Strategy

Biomarkers currently available for the diagnosis, prognosis, and therapeutic monitoring of GM1 gangliosidosis type 2 (GM1T2) disease are mainly limited to those discovered in targeted proteomic-based studies. In order to identify and establish new, predominantly low-molecular-mass biomarkers for thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Percival, Benita C., Latour, Yvonne L., Tifft, Cynthia J., Grootveld, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998791/
https://www.ncbi.nlm.nih.gov/pubmed/33807817
http://dx.doi.org/10.3390/cells10030572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998791/
https://www.ncbi.nlm.nih.gov/pubmed/33807817
http://dx.doi.org/10.3390/cells10030572

Ejemplares similares